European Primary Care Cardiovascular Society

CVRM

U-Prevent: a new tool to estimate individual effect of medication on CVD

News - Oct. 16, 2018

The UMC Utrecht's Center for Circulatory Health has developed algorithms with which the risk of CVD and the effect of medication to reduce this risk, can be predicted for every adult. Use of the risk calculators is free.

Higher healthy diet score: reduced CV disease and mortality worldwide

ESC 2018 - Munich

News - Sep. 4, 2018

ESC 2018 The PURE cohort study showed reduced risk of CV disease and mortality with high-quality diets in general populations worldwide.

Hypertension - Can we agree on diagnostic and therapeutic thresholds?

10' education - Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Prof. Richard McManus, prof. Richard Hobbs and prof. Christos Lionis
Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.

EPCCS 2018 Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.

Summary | The cardiovascular challenge for primary care in diabetes

May 3, 2018 – Prof. Richard Hobbs, MD

This summary of the presentation by prof. Hobbs illustrates why diabetes poses a high burden to primary health care, since patients with T2DM are at high CV risk. This risk can be lowered by targeting various risk factors.

Diabetes: How to reduce risk from a cardiovascular perspective?

10' education - July 12, 2018 - Prof. Diederick Grobbee - Utrecht, The Netherlands
Prof. Grobbee discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents

Prof. Grobbee discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK
Prof. Hobbs stresses  the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Clear health benefits with cost effective intense multifactorial treatment for T2DM

News - June 25, 2018

ADA 2018 In long-term Danish Steno 2 study, interventions targeting complications were found to improve disease-free-life length, and costs were not higher than with conventional treatment.

Risk of dementia increases with hypertension duration in mid-life

Literature - June 19, 2018 - Abell JG et al. - Eur Heart J 2018

Individuals with hypertension at mid-life, defined as SBP ≥130 mmHg at the age of 50, have an increased risk of dementia, which is proportional to the duration of the exposure to hypertension

No use of vitamin supplementation for CVD prevention, according to large meta-analysis

Literature - June 6, 2018 - Jenkins DJA et al., - J Am Coll Cardiol. 2018

No consistent benefit was seen of popular supplements (multivitamins, vitamin D, calcium and vitamin C) for the prevention of CVD, myocardial infarction or stroke, or on all-cause mortality.

Lipid lowering: the evidence, the guidelines, the clinical reality

EPCCS CV Summit 2018

Lecture - Mar. 16, 2018 - EPCCS 2018, Barcelona, Spain - Professor Frank Visseren, Utrecht, The Netherlands
A recording of the lecture by Prof. Visseren, on practical issues of managing elevated lipids and statins: why do many patients not take their medication, and how can we improve this?

EPCCS 2018 A recording of the lecture by Prof. Visseren, on practical issues of managing elevated lipids and statins: why do many patients not take their medication, and how can we improve this?

CV benefit of long-term statin treatment far outweighs adverse effects, says EAS Consensus Panel

Literature - May 3, 2018 - Mach F et al., Eur Atheroscl Soc Consensus Panel - Eur Heart J, 2018

Based on objective and critical appraisal of the literature on potential adverse effects of statins, the EAS Consensus Panel concludes that statin treatment is remarkably safe.

New ESC Guidelines on diagnosis and management of syncope

News - Apr. 30, 2018

A multidisciplinary ESC Task Force aimed to give as much practical advice as possible on the most appropriate management and therapy for each of the subtypes of syncope, although trial evidence is scarce.